The Montgomery–Åsberg Depression Rating Scale (MADRS) is a ten-item diagnostic questionnaire which mental health professionals use to measure the severity...
6 KB (562 words) - 06:24, 25 April 2024
Other scales include the Montgomery-Åsberg Depression Rating Scale (MADRS), the Beck Depression Inventory (BDI), the Zung Self-Rating Depression Scale, the...
14 KB (1,496 words) - 22:36, 8 July 2024
assessing the effects of drug therapy. Alternatively, the Montgomery-Åsberg Depression Rating Scale (MADRS) features ten items to be completed for the purpose...
20 KB (2,382 words) - 13:34, 3 October 2024
sub-scale for measuring the severity of depression, called the Montgomery Åsberg Depression Rating Scale (MADRS), was the most widely used rating scale for...
2 KB (178 words) - 06:23, 29 March 2022
and Depression Scale (HADS) Kutcher Adolescent Depression Scale (KADS) Major Depression Inventory (MDI) Montgomery-Åsberg Depression Rating Scale (MADRS)...
11 KB (926 words) - 02:16, 25 May 2024
Lisdexamfetamine (section Depression)
was not significantly better than placebo in improving Montgomery–Åsberg Depression Rating Scale scores, response rates, or remission rates. However, there...
45 KB (14,062 words) - 20:53, 26 October 2024
Clinical global impression (section Severity scale)
sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant...
9 KB (1,027 words) - 23:28, 8 April 2024
Dextromethorphan/bupropion (section Depression)
with major depressive disorder, scores on the Montgomery–Åsberg Depression Rating Scale (MADRS)—a scale with a range of 0 to 60 points—decreased with...
21 KB (1,819 words) - 03:20, 17 October 2024
Levomilnacipran (section Depression)
by the Montgomery–Åsberg Depression Rating Scale. Superiority to placebo was also demonstrated by improvement in the Sheehan Disability Scale. Side effects...
13 KB (1,036 words) - 06:18, 10 April 2024
on vortioxetine determined that its place in the treatment of severe depression is unclear due to low-quality evidence and that more studies comparing...
56 KB (4,811 words) - 22:41, 21 October 2024
Esketamine (section Depression)
esketamine and placebo on the Montgomery–Åsberg Depression Rating Scale (MADRS) after 4 weeks of treatment (P = 0.020). This scale ranges from 0 to 60 and the...
63 KB (6,113 words) - 07:28, 11 November 2024
Selegiline (section Depression)
antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled...
208 KB (20,169 words) - 14:42, 2 November 2024
Wake therapy (category Treatment of depression)
and reliability of a structured interview guide for the Montgomery-Åsberg Depression Rating Scale (SIGMA)". The British Journal of Psychiatry. 192 (1):...
32 KB (3,558 words) - 03:17, 7 October 2024
meet its primary effectiveness endpoint (MADRSTooltip Montgomery–Åsberg Depression Rating Scale) in MDD. However, statistically significant improvements...
39 KB (3,854 words) - 21:20, 3 September 2024
Åsberg (born 1938) is a Swedish psychiatrist. She was based at the Karolinska Institute until retirement in 2004. In a pioneering 1976 paper, Åsberg found...
3 KB (287 words) - 08:21, 13 April 2024
Bupropion (section Depression)
antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled...
137 KB (12,552 words) - 20:59, 11 November 2024
Pharmacokinetics of estradiol (category Pages using multiple image with manual scaled images)
(1989, 1990). Trough estradiol levels and MADRSTooltip Montgomery–Åsberg Depression Rating Scale scores with 1 mg sublingual micronized estradiol 3 to...
224 KB (26,885 words) - 13:02, 2 November 2024
Young Mania Rating Scale (YMRS) score from 33.1 to 17.8. A significant (p < 0.001) improvement in Montgomery–Åsberg Depression Rating Scale (MADRS) score...
15 KB (1,428 words) - 16:02, 21 October 2024
antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled...
8 KB (701 words) - 17:22, 3 December 2023
a study published in 2011, using the Montgomery–Åsberg Depression Rating Scale and the Sheehan Disability Scale, edivoxetine showed superiority over placebo...
5 KB (384 words) - 17:28, 15 July 2024
Interview Guide for the Montgomery Asberg Depression Rating Scale (SIGMA) and the Structured Interview Guide for the Hamilton Depression Scale (SIGH-D). Williams...
8 KB (873 words) - 18:51, 14 December 2023
beneficial results on patients as measured by changes on the Montgomery-Asberg Depression Rating Scale after eight weeks of treatment as compared with placebo...
13 KB (1,155 words) - 06:45, 19 April 2024
antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled...
193 KB (20,781 words) - 15:57, 6 November 2024